Sentinel node biopsy for  melanoma: The medical  oncology perspective.

Alexander M. Menzies; Victoria Atkinson; Michael P. Brown; Matteo S. Carlino; Jonathan Cebon; Alexander Guminski; Richard Kefford; Georgina V. Long; Grant A. McArthur; Catriona M. McNeil; Michael Millward; Shahneen Sandhu

Related publications

Article2008

Sentinel Lymph Node Biopsy for Melanoma: Aspects of Pathologic Assessment

Rajmohan Murali, John F. Thompson, Richard A Scolyer

Article2023

Improving Selection for Sentinel Lymph Node Biopsy Among Patients With Melanoma

James R. Miller, Serigne Lo, Mehdi Nosrati, Jonathan R. Stretch, Andrew J. Spillane, Robyn P.M. Saw, Kerwin F. Shannon, Omgo E. Nieweg, Sydney Ch’ng, Kevin B. Kim, Stanley P. L. Leong, John F. Thompson, Richard A Scolyer, Mohammed Kashani–Sabet

Article2011

32. Sentinel lymph node biopsy in patients with thin melanoma

Rajmohan Murali, Lauren E. Haydu, John F. Thompson, Richard A Scolyer

Article2022

Time interval between diagnostic excision-biopsy of a primary melanoma and sentinel node biopsy: effects on the sentinel node positivity rate and survival outcomes

Mary‐Ann El Sharouni, Richard A Scolyer, Carla H. van Gils, Sydney Ch’ng, Omgo E. Nieweg, Thomas E. Pennington, Robyn P.M. Saw, Kerwin F. Shannon, Andrew J. Spillane, Jonathan R. Stretch, Arjen J. Witkamp, V. Sigurdsson, John F. Thompson, P. J. van Diest, Serigne Lo

Article2011

Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma

Rajmohan Murali, Lauren E. Haydu, Michael J. Quinn, Robyn P.M. Saw, Kerwin F. Shannon, Andrew J. Spillane, Jonathan R. Stretch, John F. Thompson, Richard A Scolyer

Sentinel node biopsy for melanoma: The medical oncology perspective.

Discussion(0)